🔗 Share this article

Chancellor Rachel Reeves has announced she is planning "targeted steps to address household expense challenges" in the forthcoming financial statement.

In comments to media outlets, she stated that curbing inflation is a joint responsibility of both the government and the central bank.

The UK's inflation rate is expected to be the highest among the G7 developed nations this year and the following year.

Possible Energy Bill Interventions

Reports indicate the administration could intervene to lower utility costs, for instance by slashing the current 5% level of VAT applied on energy supplies.

Another approach is to reduce some of the regulatory levies currently included in bills.

Fiscal Limitations and Expert Predictions

The government will receive the next draft from the official forecaster, the OBR, on Monday, which will show how much scope there is for such actions.

The expectation from most economists is that Reeves will have to declare higher taxes or expenditure reductions in order to fulfill her self-imposed debt limits.

Earlier on the same day, estimates showed there was a £22bn gap for the Treasury chief to address, which is at the lower end of projections.

"There's a collective task between the central bank and the government to bear down further on some of the drivers of inflation," Reeves informed the BBC in the US capital, at the yearly gatherings of the IMF and global financial institution.

Tax Pledges and Global Issues

While much of the focus has been on likely tax increases, the chancellor said the latest data from the OBR had not changed her pledge to election pledges not to increase tax levels on earnings tax, sales tax or National Insurance.

She blamed an "unpredictable global environment" with increasing geopolitical and trade issues for the fiscal tax moves, probably to be directed on those "with the broadest shoulders."

Global Trade Disputes

Referring to worries about the UK's economic relations with China she said: "The UK's security interests always come first."

Recent declaration by China to strengthen export controls on critical minerals and other materials that are crucial for high-technology production led American leader the US President to threaten an extra 100% tariff on imports from China, raising the possibility of an all-out commercial conflict between the two economic giants.

The American finance chief called China's decision "commercial pressure" and "a international production power grab."

Asked about accepting the American proposal to join its dispute with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and urged the Chinese government "to avoid restrictions and limit trade."

She said the action was "bad for the world economy and generates additional headwinds."

"I believe there are sectors where we need to address Chinese policies, but there are also important chances to sell into China's economy, including banking sector and other areas of the economic system. We've got to get that balance right."

The chancellor also affirmed she was working with international partners "regarding our own critical minerals plan, so that we are more independent."

NHS Medicine Pricing and Funding

The Chancellor also acknowledged that the cost the NHS spends on medicines could go up as a result of current discussions with the US government and its pharmaceutical firms, in return for lower tariffs and funding.

Some of the world's largest pharmaceutical manufacturers have said lately that they are either pausing or canceling projects in the United Kingdom, with some blaming the modest returns they are receiving.

Last month, the government science advisor said the price the NHS spends on medicines would need to rise to prevent businesses and pharmaceutical investment departing from the UK.

The Chancellor informed media: "We have seen because of the cost structure, that clinical trials, innovative medicines have not been provided in the United Kingdom in the manner that they are in other continental states."

"We want to guarantee that people receiving care from the National Health Service are can obtain the finest essential drugs in the globe. And so we are looking at all of that, and... looking to obtain more funding into Britain."